Knockdown of IGF-1 expression level via applying a CRISPR/Cas9 genome editing system could suppress the activation of AKT and Hedgehog signaling pathways, and thereby inhibiting cell proliferation, migration, and tumor aggressiveness in OSCC cells. The gene discussed is IGF1; the disease is neoplasm.